| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President & CSO | President & CSO | President & CEO +1 more
1 company
Jaume Pons last filed a Form 4 in February 2025, as President & CSO at ALXO. From July 2020 to February 2025, the filings on record show 0 open-market purchases and 21 sales. Jaume Pons's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Jaume Pons's trades have earned a strong insider score of 89/100 across 20 rated trades. Over a 12-month horizon, 90.0% of those trades were profitable, with an average 12-month return of +64.5%.
At the last filing, the largest reported position was 579,388 shares of ALXO. The ALXO filings lean toward selling, a net 318,736 shares.
Shares as reported in the last Form 4 for each company; the most recent is from February 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22, 2021 | ALXO Alx Oncology Holdings Inc | President and CEO | Sale+OE | 16,700 | $68.49 | $1,143,860.49 | -2.9% | -15.5% | -73.0% |